Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes

被引:108
作者
Sur, S
Glitz, DG
Kita, H
Kujawa, SM
Peterson, EA
Weiler, DA
Kephart, GM
Wagner, JM
George, TJ
Gleich, GJ [1 ]
Leiferman, KM
机构
[1] Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Dermatol, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Mayo Med Sch, Rochester, MN 55905 USA
[5] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA
关键词
immunofluorescence; reverse transcription-polymerase chain reaction; electron microscopy;
D O I
10.1002/jlb.63.6.715
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP) are generally regarded as eosinophil-specific proteins. We tested whether EDN and ECP are present iu mature neutrophils, By indirect immunofluorescence, both eosinophils and neutrophils stained with antibodies to EDN and ECP. Lq-sates of purified (<0.1% eosinophil contamination) neutrophils contained EDN, 112 +/- 4 ng/10(6) cells, and ECP, 163 +/- 2 ng/10(6) cells, whereas eosinophil major basic protein (MBP) was not detectable. Electron microscopic examination of immunogold-labeled buffy coat cells stained with EDN antibody showed that EDN is localized to neutrophil granules. Finally, EDN mRNA was detected in lysates of highly purified neutrophils (0.001% eosinophil contamination) by the reverse transcription-polymerase chain reaction, We conclude that proteins that are either identical to or immunologically crossreactive with EDN and ECP are present in neutrophils and that EDN is synthesized and localized to neutrophil granules. Thus, caution must be exercised in interpreting the presence of EDN and ECP as specific markers of eosinophil-associated inflammation in human disease.
引用
收藏
页码:715 / 722
页数:8
相关论文
共 37 条
[1]   EOSINOPHIL GRANULE PROTEINS IN PERIPHERAL-BLOOD GRANULOCYTES [J].
ABUGHAZALEH, RI ;
DUNNETTE, SL ;
LOEGERING, DA ;
CHECKEL, JL ;
KITA, H ;
THOMAS, LL ;
GLEICH, GJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 52 (06) :611-618
[2]  
ACKERMAN SJ, 1983, J IMMUNOL, V131, P2977
[3]   LOCALIZATION OF EOSINOPHIL GRANULE MAJOR BASIC-PROTEIN IN HUMAN BASOPHILS [J].
ACKERMAN, SJ ;
KEPHART, GM ;
HABERMANN, TM ;
GREIPP, PR ;
GLEICH, GJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (03) :946-961
[4]  
ADELROTH E, 1990, AM REV RESPIR DIS, V142, P91
[5]   EOSINOPHILS AND EOSINOPHIL CATIONIC PROTEIN IN NASAL LAVAGES IN ALLERGEN-INDUCED HYPERRESPONSIVENESS - EFFECTS OF TOPICAL GLUCOCORTICOSTEROID TREATMENT [J].
ANDERSSON, M ;
ANDERSSON, P ;
VENGE, P ;
PIPKORN, U .
ALLERGY, 1989, 44 (05) :342-348
[6]  
BARKER RL, 1989, J IMMUNOL, V143, P952
[7]   ALLERGEN-INDUCED INCREASE OF EOSINOPHIL CATIONIC PROTEIN IN NASAL LAVAGE FLUID - EFFECT OF THE GLUCOCORTICOID BUDESONIDE [J].
BISGAARD, H ;
GRONBORG, H ;
MYGIND, N ;
DAHL, R ;
LINDQVIST, N ;
VENGE, P .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (05) :891-895
[8]   INDIRECT EVIDENCE OF BRONCHIAL INFLAMMATION ASSESSED BY TITRATION OF INFLAMMATORY MEDIATORS IN BAL FLUID OF PATIENTS WITH ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
ENANDER, I ;
VENGE, P ;
PETERSON, C ;
AHLSTEDT, S ;
MICHEL, FB ;
GODARD, P .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) :649-660
[9]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[10]   EOSINOPHILS, T-LYMPHOCYTES, MAST-CELLS, NEUTROPHILS, AND MACROPHAGES IN BRONCHIAL BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITH ASTHMA - COMPARISON WITH BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITHOUT ASTHMA AND NORMAL CONTROL SUBJECTS AND RELATIONSHIP TO BRONCHIAL HYPERRESPONSIVENESS [J].
BRADLEY, BL ;
AZZAWI, M ;
JACOBSON, M ;
ASSOUFI, B ;
COLLINS, JV ;
IRANI, AMA ;
SCHWARTZ, LB ;
DURHAM, SR ;
JEFFERY, PK ;
KAY, AB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) :661-674